Alternating Electric Field Tumor Treatment System Optune and Services

Sole-source notice

Japanese title: 交流電場腫瘍治療システムオプチューン及びサービス提供一式令和年月日木曜日 (号外政府調達第号) 官報

This single tendering procedure concerns the procurement of the alternating electric field tumor treatment system Optune and related services by Hiroshima University Hospital. The contract is planned for August 31, 2026, awarded to Novocure K.K. due to technical reasons precluding competition.

Medical

Key Details

  • Source: Kanpo
  • Notice type: Sole-source notice
  • Publication date: July 23, 2026
  • Procuring entity: Adachi Nobuo, Director of the Hospital, Hiroshima University
  • Planned contract date: August 31, 2026
  • Intended vendor: Novocure K.K.
  • Status: Active
  • Technology relevance: Possible
  • Business-action likelihood: Medium – The tender is a single-source contract awarded to Novocure K.K. due to technical reasons, limiting open competition but allowing potential partnership or supply opportunities.

Business Relevance

May interest companies providing advanced medical treatment systems and related service solutions, particularly in oncology device technologies.

Participation fit

This procedure is classified as sole-source and is not an open competitive tender. Direct participation is not applicable, but the notice may indicate existing government demand and active relevant vendors in Japan.

Official Source

This opportunity is based on a tender notice published in Kanpo, the official gazette of the Government of Japan.

  • Source: Kanpo, Government Procurement Notice Edition
  • Official category: 随意契約に関する公示 / Notice of single tendering procedures
  • Publication date: July 23, 2026
  • Publication: Kanpo, pages 35

Full English Translation

The following English translation was prepared from the original Japanese notice published in Kanpo. Where an official English summary appears in the Kanpo publication, it was used only for verification; the translation below is based on the Japanese source text.

Notice of single tendering procedures as follows. Date: July 23, 2026. Procuring entity: Hiroshima University Hospital, Contract Officer: Adachi Nobuo. Procurement agency number: 415. Location number: 34. Item classification numbers: 22, 31. Subject and quantity: Alternating Electric Field Tumor Treatment System Optune and full service provision. Scheduled date of single tender contract: August 31, 2026. Reason for single tendering under the Government Procurement Agreement: b) No competition due to technical reasons. Intended contracting party: Novocure K.K. Contact department: Hiroshima University Hospital SPD Center, Shinbaku Yoichi, Phone: 082-257-5030.

Show original Japanese notice

随意契約に関する公示

次のとおり随意契約について公示します。 令和8年7月23日国立大学法人広島大学分任契約担当職病院長安達伸生
◎調達機関番号415 ◎所在地番号34
〇第4号

1 調達内容
(1) 品目分類番号22、31
(2) 購入等件名及び数量交流電場腫瘍治療システムオプチューン及びサービス提供一式

2 随意契約の予定日令和8年8月31日

3 随意契約によることとする「政府調達に関する協定」の規定上の理由 b「技術的理由による競争の不存在」

4 随意契約を予定している相手方の名称ノボキュア株式会社5担当部門 〒734-8551広島市南区霞一丁目2番3号広島大学病院SPDセンター新迫洋一電話082-257-5030

Disclaimer

This page is based on the official Kanpo tender notice, with translation and a preliminary business assessment by I.J. Do. The official Japanese notice and tender documents are binding.

JBid is a beta technology-procurement intelligence service by I.J. Do.

Back to daily list